Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Literature-based translation from synthetic lethality screening into therapeutics targets: CD82 is a novel target for KRAS mutation in colon cancer. | Comput Struct Biotechnol J | 2022 | 36212540 | PubTator, text mining | PubMed |
| An overview of resistance to chemotherapy in osteosarcoma and future perspectives. | Cancer Drug Resist | 2022 | 36176756 | PubTator, text mining | PubMed |
| Replication Compartments of Eukaryotic and Bacterial DNA Viruses: Common Themes Between Different Domains of Host Cells. | Annu Rev Virol | 2022 | 36173697 | PubTator, text mining | PubMed |
| Creation and resolution of non-B-DNA structural impediments during replication. | Crit Rev Biochem Mol Biol | 2022 | 36170051 | PubTator, text mining | PubMed |
| ASPM promotes ATR-CHK1 activation and stabilizes stalled replication forks in response to replication stress. | Proc Natl Acad Sci U S A | 2022 | 36161901 | PubTator, text mining | PubMed |
| The Multi-Omic Landscape of Primary Breast Tumors and Their Metastases: Expanding the Efficacy of Actionable Therapeutic Targets. | Genes (Basel) | 2022 | 36140723 | PubTator, text mining | PubMed |
| Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer. | JAMA Netw Open | 2022 | 36136330 | PubTator, text mining | PubMed |
| CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer. | Proc Natl Acad Sci U S A | 2022 | 36129942 | PubTator, text mining | PubMed |
| WRN promotes bone development and growth by unwinding SHOX-G-quadruplexes via its helicase activity in Werner Syndrome. | Nat Commun | 2022 | 36114168 | PubTator, text mining | PubMed |
| Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes. | Cancer Discov | 2022 | 36098958 | PubTator, text mining | PubMed |
| Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy. | Front Immunol | 2022 | 36091058 | PubTator, text mining | PubMed |
| The in vivo Interaction Landscape of Histones H3.1 and H3.3. | Mol Cell Proteomics | 2022 | 36089195 | PubTator, text mining | PubMed |
| An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer. | Front Genet | 2022 | 36081989 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome. | Cancers (Basel) | 2022 | 36077770 | PubTator, text mining | PubMed |
| S1-END-seq reveals DNA secondary structures in human cells. | Mol Cell | 2022 | 36075220 | PubTator, text mining | PubMed |
| Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer. | Front Oncol | 2022 | 36072793 | PubTator, text mining | PubMed |
| de novo variant calling identifies cancer mutation signatures in the 1000 Genomes Project. | Hum Mutat | 2022 | 36054329 | PubTator, text mining | PubMed |
| Recognition and unfolding of human telomeric G-quadruplex by short peptide binding identified from the HRDC domain of BLM helicase. | RSC Adv | 2022 | 36043100 | PubTator, text mining | PubMed |
| Mammalian Resilience Revealed by a Comparison of Human Diseases and Mouse Models Associated With DNA Helicase Deficiencies. | Front Mol Biosci | 2022 | 36032672 | PubTator, text mining | PubMed |
| Genome Protection by DNA Polymerase θ. | Annu Rev Genet | 2022 | 36028228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=25